1. Oncotarget. 2011 Dec;2(12):1127-33. doi: 10.18632/oncotarget.385.

Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased 
human height.

Tatton-Brown K(1), Hanks S, Ruark E, Zachariou A, Duarte Sdel V, Ramsay E, Snape 
K, Murray A, Perdeaux ER, Seal S, Loveday C, Banka S, Clericuzio C, Flinter F, 
Magee A, McConnell V, Patton M, Raith W, Rankin J, Splitt M, Strenger V, Taylor 
C, Wheeler P, Temple KI, Cole T; Childhood Overgrowth Collaboration; Douglas J, 
Rahman N.

Collaborators: Amor D, Andries S, Archer H, Armstrong R, Ashton-Prolla P, 
Baralle D, Barnicoat A, Barrow M, Beales P, Becker K, Beckh-Arnold E, Berg J, 
Bernhard B, Bhat M, Birch J, Bitner M, Blair E, Bliek J, Blyth M, Brady A, Brice 
G, Brueton L, Burn J, Canham N, Castle B, Cecconi M, Chandler K, Chandrasena R, 
Cilliers D, Clarke A, Clayton-Smith J, Clericuzio C, Cole T, Colley A, Collins 
A, Connell F, Cook J, Crow Y, Dabir T, Dalton A, Danda S, Davies S, Day R, 
Dennis N, Deshpande C, Desouza B, Devlin L, Differ AM, Dinwiddie R, Dobbie A, 
Donnai D, Ellis I, Elmslie F, Firth H, Fisher R, Fitzpatrick D, Flinter F, Foley 
P, Foulds N, Fryer A, Gallagher A, Garcia S, Gardiner C, Gibbons R, Gillerot Y, 
Goudie D, Gowrishanker K, Graham C, Gregersen N, Harper J, Hughes H, Henderson 
A, Hennekam R, Hobson E, Holder S, Homfray T, Huma Z, Hurst J, Irving M, Izatt 
L, Jagadeeth S, Jessen C, Johnson D, Josifova D, Joss S, Kerr B, Liebelt J, Kini 
U, Krause A, Kumar A, Kumar D, Lam W, Lapunzina P, Lees M, Leonard N, Livesey A, 
Longman C, Lucassen A, Lunt P, Lynch S, MacDonnell J, Magee A, Maher E, Male A, 
Mansour S, McConnell V, McEntagart M, McKee S, McKeown C, Mehta S, Metcalfe K, 
Mohammed S, Monaghan G, Montgomery T, Morgan A, Morrison P, Morton J, Mudgal R, 
Murday V, Nampoothiri S, Nemeth A, Newbury-Ecob R, Oley C, Owen C, Park SM, 
Parker M, Patel C, Patton M, Pilz D, Pinkney M, Pocha M, Pottinger C, Prescott 
K, Price S, Proctor A, Quarrell O, Rankin J, Raymond L, Rea G, Reardon W, Reid 
E, Robards M, Roposch A, Rosser E, Rourke D, Ruddy D, Saggar A, Sampson J, 
Sandford R, Sarkar A, Scott R, Semple R, Sharif S, Shaw A, Shaw-Smith C, Shears 
D, Shelagh J, Smith G, Smithson S, Splitt M, Stevens M, Stewart F, Stewart H, 
Stopps K, Suri M, Sweeney E, Tanateles G, Taylor C, Temple K, Tischowitz M, 
Tolmie J, Tomkins S, Turnpenny P, Van-Haelst M, Van Maldergem L, Vandersteen A, 
Vasudevan P, Wakeling E, Walker L, Williams D, Wilson L, Woods G, Wright M, 
Zankl A.

Author information:
(1)Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, 
UK.

Erratum in
    Oncotarget. 2018 Nov 30;9(94):36719. doi: 10.18632/oncotarget.26429.

Comment in
    Oncotarget. 2012 Jan;3(1):1-2. doi: 10.18632/oncotarget.435.
    Oncotarget. 2012 Jan;3(1):3-4. doi: 10.18632/oncotarget.436.

The biological processes controlling human growth are diverse, complex and 
poorly understood. Genetic factors are important and human height has been shown 
to be a highly polygenic trait to which common and rare genetic variation 
contributes. Weaver syndrome is a human overgrowth condition characterised by 
tall stature, dysmorphic facial features, learning disability and variable 
additional features. We performed exome sequencing in four individuals with 
Weaver syndrome, identifying a mutation in the histone methyltransferase, EZH2, 
in each case. Sequencing of EZH2 in additional individuals with overgrowth 
identified a further 15 mutations. The EZH2 mutation spectrum in Weaver syndrome 
shows considerable overlap with the inactivating somatic EZH2 mutations recently 
reported in myeloid malignancies. Our data establish EZH2 mutations as the cause 
of Weaver syndrome and provide further links between histone modifications and 
regulation of human growth.

DOI: 10.18632/oncotarget.385
PMCID: PMC3282071
PMID: 22190405 [Indexed for MEDLINE]